Anti-müllerian hormone as an fertility indicator in women of late reproductive age

Korolkova A.I.; Mishieva N.G.; Abubakirov A.N.; Pavlova Yu.S.; Imieva T.B.

doi:https://doi.org/10.17116/repro201824223-27

Korolkova A.I.

Department of Preservation and Restoration of Reproductive Function National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov of Ministry of Healthcare of Russia. Academic Oparin str. 4, Moscow, Russia, 117997

Mishieva N.G.

FGU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Abubakirov A.N.

FGU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Pavlova Yu.S.

Institute of Professional Education, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia, 119991

Imieva T.B.

Department of Obstetrics and Gynecology of medical faculty of Ingush State University, Magas, Russia, 386001

Anti-müllerian hormone as an fertility indicator in women of late reproductive age

Authors:

Korolkova A.I., Mishieva N.G., Abubakirov A.N., Pavlova Yu.S., Imieva T.B.

More about the authors

Journal: Russian Journal of Human Reproduction. 2018;24(2): 23‑27

DOI: 10.17116/repro201824223-27

Read: 1949 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Korolkova AI, Mishieva NG, Abubakirov AN, Pavlova YuS, Imieva TB. Anti-müllerian hormone as an fertility indicator in women of late reproductive age. Russian Journal of Human Reproduction. 2018;24(2):23‑27. (In Russ.)
https://doi.org/10.17116/repro201824223-27

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)

Использование инфографики авторами научных работ

Close metadata

Abstract:

This review discusses the available data in world literature about fertility in women of late reproductive age undergoing in vitro fertilization (IVF) and the role of the serum anti-Mullerian hormone levels (AMH) as a predictor of IVF outcomes in this group of patients. On the basis of different authors data, there is no the certain threshold level of AMH below which pregnancy would be excluded in women of late reproductive age. The difference between studies may be partially explained by the use of various methods for estimating the concentration of AMH. Unfortunately, existing methods of evaluation do not reliably predict the outcome of infertility treatment in patients with low values of AMH, especially in women older than 42 years. However, it is very important to have the accurate statistics of IVF cycles outcomes in patients of advanced reproductive age for making decision of infertility treatment possibility.

Keywords:

late reproductive age

anti-Mullerian hormone

clinical pregnancy

biochemical pregnancy

Assisted Reproductive Technology

ART

in vitro fertilization

IVF

live birth rate

Authors:

Korolkova A.I.

Mishieva N.G.

FGU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Abubakirov A.N.

FGU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Pavlova Yu.S.

Institute of Professional Education, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia, 119991

Imieva T.B.

Department of Obstetrics and Gynecology of medical faculty of Ingush State University, Magas, Russia, 386001

Close metadata

References:

Meczekalski BA, Czyzyk M, Kunicki A, Podfigurna-Stopa L, Plociennik G, Jakiel M, Maciejewska-Jeske, Lukaszuk K. Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment. J Endocrinol Invest. 2016;39:1259-1265. https://doi.org/10.1007/s40618-016-0497-6
Smith KE, Buyalos RP. The profound impact of patient age on pregnancy outcome after early detection of fetal cardiac activity. Fertil Steril. 1996;65(1):35-40. https://doi.org/10.1016/S0015-0282(16)58024-8
Gleicher N, Kushnir VA, Albertini DF, Barad DH. Improvements in IVF in women of advanced age. Society for Endocrinology. 2016. https://doi.org/10.1530/JOE-16-0105
Yamada Z, Kitagawa M, Takemura T, Hirokawa K. Effect of maternal age on incidences of apoptotic and proliferative cells in trophoblasts of full-term human placenta. Mol Hum Reprod. 2001;7:1179-1185.
Mishieva NG. Infertility in women of late reproductive age: the principles of diagnosis and treatment, depending on the ovarian reserve: Dis... doctor honey sciences. M. 2008;48. (In Russ.)
Lukaszuk K, Jakiel G, Kuczynski W, Pukszta S, Liss J, Plociennik L, Lukaszuk A, Pastuszek E. Next generation sequencing for preimplantation genetic testing of blastocysts aneuploidies in women of different ages. Ann Agric Environ Med. 2016;23(1):163-166. https://doi.org/10.5604/12321966.1196874
Brezina PR, Anchan R, Kearns WG. Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences? J Assist Reprod Genet. 2016 Jul;33(7):823-832. https://doi.org/10.1007/s10815-016-0740-2
Ma GC, Chen HF, Yang YS, Lin WH, Tsai FP, Lin CF, Chiu C, Chen M. A pilot proof-of-principle study to compare fresh and vitrified cycle preimplantation genetic screening by chromosome microarray and next generation sequencing. Mol Cytogenet. 2016 Mar 21;9:25. https://doi.org/10.1186/s13039-016-0238-8
te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8:141-154. https://doi.org/10.1093/humrep/deg126
Klein NA, Harper AJ, Houmard BS, Sluss PM, Soules MR. Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development? J Clin Endocrinol Metab. 2002;87:5746-5750. https://doi.org/10.1210/jc.2002-020622
Wu Y, Zhang N, Li YH, Zhao L, Yang M, Jin Y, Xu YN, Guo H. Citrinin exposure affects oocyte maturation and embryo development by inducing oxidative stress-mediated apoptosis. Oncotarget. 2017 Feb 28. https://doi.org/10.18632/oncotarget.15776
Ogino M, Tsubamoto H, Sakata K, et al. Mitochondrial DNA copy number in cumulus cells is a strong predictor of obtaining good-quality embryos after IVF. J Assist Reprod Genet. 2016 Mar;33(3):367-371. https://doi.org/10.1007/s10815-015-0621-0
Korolkova AI, Mishieva NG, Burmenskaya OV, Ekimov AN, Abubakirov AN, Bogatyreva KhA. Current methods of embryo selection during carry out of assisted reproductive technique programs. Obstetrics and Gynecology. 2018;02. (In Russ.)
Freeman EW, Sammel MD, Lin H, Gracia CR. Antimullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab. 2012;97(5):1673-1680. https://doi.org/10.1210/jc.2011-3032
Broekmans FJ, Visser JA, Laven JS. Anti-mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab. 2008;19:340-347.
Hutson J, Ikawa H, Donahoe PK. The ontogeny of Mul- lerian inhibiting substance in the gonads of the chicken. J Pediatr Surg. 1981;16:822-827.
de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77(2):357-362.
Human Fertilisation and Embryology Authority (HFEA). Fertility treatment in 2010: trends and figures. HFEA 2010, London. www.hfea.gov.uk/104.html
Weghofer A, Dietrich W, Barad DH, Gleicher N. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Hum Reprod. 2011;26(7):1905-1909. https://doi.org/10.1093/humrep/der134
Lukaszuk K, Kunicki M, Liss J, Bednarowska A, Jakiel G. Probability of live birth in women with extremely low anti-Müllerian hormone concentrations. Reprod Biomed Online. 2014;28(1):64-69. https://doi.org/10.1016/j.rbmo.2013.09.017
Kedem A, Haas J, Geva LL, Yerushalmi G, Gilboa Y, Kanety H, Hanochi M, Maman E, Hourvitz A. Ongoing pregnancy rates in women with low and extremely low AMH levels. A multivariate analysis of 769 cycles. PLoS ONE. 2013;8(12):e81629. https://doi.org/10.1371/journal.pone.0081629
Reichman DE, Goldschlag D, Rosenwaks Z. Value of antimullerian hormone as a prognostic indicator of in vitro fertilization outcome. Fertil Steril. 2014;10:1012-1018. https://doi.org/10.1016/j.fertnstert.2013.12.039
Seifer DB, Tal O, Wantman E, Edul P, Baker VL. Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum anti-müllerian hormone: a multivariate analysis of over 5000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012–2013. Fertil Steril 2015;S0015-S0282(15):02011-02017. https://doi.org/10.1016/j.fertnstert.2015.10.004
Cagnone GLM, Te-Sha Tsai, Yogeshwar Makanji, Matthews P, Gould J, Bonkowski MS, Elgass KD, Wong ASA, Wu LE, McKenzie M, Sinclair DA, St John JC. Restoration of normal embryogenesis by mitochondrial supplementation in pig oocytes exhibiting mitochondrial DNA deficiency. Sci Rep. 2016 Mar 18;6:23229. https://doi.org/10.1038/srep23229
El Shourbagy SH, Spikings EC, Freitas M, St John JC. Mitochondria directly influence fertilisation outcome in the pig. Reproduction. 2006 Feb;131(2):233-245.https://doi.org/10.1530/rep.1.00551
Simsek-Duran F, Li F, Ford W, Swanson RJ, Jones HWJr, Castora FJ. Age-associated metabolic and morphologic changes in mitochondria of individual mouse and hamster oocytes. PLoS One. 2013;8:e64955. https://doi.org/10.1371/journal.pone.0064955
Fragouli E, Spath K, Alfarawati S, et al. Altered levels of mitochondrial DNA are associated with female age, aneuploidy, and provide an independent measure of embryonic implantation potential. PLoS Genet. 2015;11(6):e1005241. https://doi.org/10.1371/journal.pgen.1005241
Skulachev V, Bogachev A, Kasparinsky F. Membrane bioenergetics. M.: Publishing House of Moscow University. M. 2010; 367. (In Russ.)